2020 Annual Meeting | C87 - Peripheral Neuropathy 1: Anatomical Basis and Acquired Demyelinating Neuropathies

��ɫ��

2020 Annual Meeting | C87 - Peripheral Neuropathy 1: Anatomical Basis and Acquired Demyelinating Neuropathies

Date Monday 04/27/20

Time 07:00 AM - 09:00 AM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) David N. Herrmann, MD, FAAN

Topic(s) Neuromuscular and Clinical Neurophysiology (EMG)

Learning Objectives Participants should be able to describe the clinical features, diagnostic approach/criteria, and treatment paradigms for Guillain-Barre syndrome and its variants, acute nutritional neuropathies, and CIDP.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Program Level Intermediate

Program Tracks Advanced Practice Provider

Recommended Audience Fellow, Resident, General Neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Didactic

Event Timeline
07:00 AM - 07:05 AM	Introduction	Introduction David N. Herrmann, MD, FAAN
07:05 AM - 07:40 AM	Speaker	Guillain-Barré Syndrome David N. Herrmann, MD, FAAN
07:40 AM - 08:15 AM	Speaker	Acute Nutritional Axonal Neuropathy Eric L. Logigian, MD, FAAN
08:15 AM - 08:50 AM	Speaker	Chronic Inflammatory Demyelinating Polyradiculoneuropathy Peter D. Creigh, MD
08:50 AM - 09:00 AM	Q&A	Questions and Answers

Faculty Disclosures
Eric L. Logigian, MD, FAAN	Dr. Logigian has nothing to disclose.
David N. Herrmann, MD, FAAN	Dr. Herrmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acceleron. Dr. Herrmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint global. Dr. Herrmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Herrmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Dr. Herrmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. Dr. Herrmann has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regenacy. Dr. Herrmann has received intellectual property interests from a discovery or technology relating to health care.
Peter D. Creigh, MD	No disclosure on file

��ɫ����

��ɫ����

��ɫ��

��ɫ��